Therese Juul1, Hossam Elfeki1,2, Peter Christensen1, Søren Laurberg1, Katrine J Emmertsen1,3, Palle Bager4. 1. Department of Surgery, Aarhus University Hospital, Aarhus, Denmark. 2. Department of Surgery, Mansoura University Hospital, Mansoura, Egypt. 3. Surgical Department K, Regional Hospital Randers, Denmark. 4. Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark.
Abstract
OBJECTIVE: To provide normative data for the Low Anterior Resection Syndrome (LARS) score. BACKGROUND: The LARS score is a validated and frequently used tool measuring bowel dysfunction after sphincter sparing surgery for rectal cancer. The interpretation of LARS score results has previously been limited by the lack of normative data. METHODS: An age and sex-stratified random sample of 3440 citizens from the general population was drawn from the Danish civil registration system (age range 20-89 years, 50% females). A brief questionnaire including the LARS score and health-related items were distributed electronically or by post. RESULTS: A total of 1875 (54.5%) responded, 54.0% were females. In the age group 50 to 79 years, relevant for most rectal cancer studies, the response rate was 70.5% (n = 807). In this specific age group, 18.8% of the females and 9.6% of the males had a LARS score ≥30, corresponding to the LARS score category "major LARS" (P = 0.001), and the median (interquartile range) LARS score was 16 (7-26) and 11 (4-22), respectively (P < 0.001). Responders with physical disease had a statistically significant higher risk of a LARS score ≥30, compared with responders without any physical disease (odds ratio 2.2, 95% confidence interval 1.6-2.9, P < 0.001). CONCLUSIONS: A LARS score ≥30 (major LARS) is common in the general population, especially in the age group 50 to 79 years. Normative data for the LARS score are now available and can be taken into account when interpreting LARS score results in scientific studies of bowel function after rectal cancer treatment.
OBJECTIVE: To provide normative data for the Low Anterior Resection Syndrome (LARS) score. BACKGROUND: The LARS score is a validated and frequently used tool measuring bowel dysfunction after sphincter sparing surgery for rectal cancer. The interpretation of LARS score results has previously been limited by the lack of normative data. METHODS: An age and sex-stratified random sample of 3440 citizens from the general population was drawn from the Danish civil registration system (age range 20-89 years, 50% females). A brief questionnaire including the LARS score and health-related items were distributed electronically or by post. RESULTS: A total of 1875 (54.5%) responded, 54.0% were females. In the age group 50 to 79 years, relevant for most rectal cancer studies, the response rate was 70.5% (n = 807). In this specific age group, 18.8% of the females and 9.6% of the males had a LARS score ≥30, corresponding to the LARS score category "major LARS" (P = 0.001), and the median (interquartile range) LARS score was 16 (7-26) and 11 (4-22), respectively (P < 0.001). Responders with physical disease had a statistically significant higher risk of a LARS score ≥30, compared with responders without any physical disease (odds ratio 2.2, 95% confidence interval 1.6-2.9, P < 0.001). CONCLUSIONS: A LARS score ≥30 (major LARS) is common in the general population, especially in the age group 50 to 79 years. Normative data for the LARS score are now available and can be taken into account when interpreting LARS score results in scientific studies of bowel function after rectal cancer treatment.
Authors: S Y Parnasa; H Chill; B Helou; A Cohen; R Alter; D Shveiky; I Mizrahi; M Abu-Gazala; A J Pikarsky; N Shussman Journal: Tech Coloproctol Date: 2022-09-12 Impact factor: 3.699
Authors: Felipe Quezada-Diaz; Rosa M Jimenez-Rodriguez; Emmanouil P Pappou; J Joshua Smith; Sujata Patil; Iris Wei; Jose G Guillem; Philip B Paty; Garrett M Nash; Martin R Weiser; Julio Garcia-Aguilar Journal: J Gastrointest Surg Date: 2018-10-22 Impact factor: 3.452
Authors: R Hompes; J A Cornish; I Vogel; N Reeves; P J Tanis; W A Bemelman; J Torkington Journal: Tech Coloproctol Date: 2021-04-01 Impact factor: 3.781
Authors: Felipe F Quezada-Diaz; J Joshua Smith; Rosa M Jimenez-Rodriguez; Isaac Wasserman; Emmanouil P Pappou; Sujata Patil; Iris H Wei; Garrett M Nash; Jose G Guillem; Martin R Weiser; Philip B Paty; Julio Garcia-Aguilar Journal: Dis Colon Rectum Date: 2020-07 Impact factor: 4.412